4D Molecular Therapeutics (FDMT) PT Lowered to $26 at RBC Capital
Tweet
Share
E-mailGet Alerts FDMT Hot Sheet
Price: $11.65 -1.85%
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
RBC Capital analyst Lisa Walter lowered the price target on 4D Molecular Therapeutics (NASDAQ: FDMT) to $26.00 (from $35.00) while maintaining a Outperform rating.
You May Also Be Interested In
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
- Legence Corp (LGN) PT Lowered to $100 at BTIG
- Adyen NV (ADYEN:NA) (ADYYF) PT Raised to EUR1,200 at Susquehanna
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
